Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer, effective Feb. 15. She succeeds longtime CEO Maryann Roefaro, who is retiring from the position ...
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
2d
St. Francis Hospital’s internal medicine residency program received its first fellowship training matches. MD, MSC Andrew ...
Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...
The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...
TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...
Kite Pharma is flying high with the addition of a new member to its senior leadership team. | Kite Pharma is flying high with ...
The American Cancer Society projected approximately 2 million new cancer diagnoses and 618,000 new cancer deaths in the U.S.
The global hematology diagnostic market is projected to grow from USD 780.0 million in 2023 to USD 2.0 billion by 2033, at a ...
Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...
Rachna Shroff, MD, is the associate director of clinical investigations at the U of A Cancer Center and a professor and chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback